Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.32 |
| ▸ | F2 | P00734 | 2/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.32 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.32 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ALB | P02768 | 1/20 | 0.30 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.30 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063054 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL24461912 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL3063389 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL24461915 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL3071899 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL24461929 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| Hydrochloric Acid SCHEMBL10825779 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL3070655 | 0.97 | MEN1 (0.43) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL18843497 | 0.95 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 | |
| SCHEMBL29183478 | 0.91 | PAOX (0.45) | SMN1; SMN2MEN1CYP1A2KMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102455-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL TECHNOLOGIES, LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12588450-B2 | Post-CMP cleaning liquid comprising a substituted benzene anticorrosive agent, chelant, and amine compound | FUJIFILM CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20260053136-A1 | SANITIZING AND DISINFECTING COMPOSITIONS WITH DWELL TIME INDICATORS AND CLEANING ARTICLES CONTAINING THE SAME | KIMBERLY CLARK CO (US) | 2026-02-26 | — | — | US | disclosed |
| US-12480072-B2 | Cleaning fluid and cleaning method | FUJIFILM CORPORATION (JP) | 2025-11-25 | — | — | US | disclosed |
| WO-2025217285-A9 | METHODS OF TREATING HARD TISSUE WITH BIOCOMPATIBLE MATERIAL | ROCHAL TECHNOLOGIES LLC (US) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025217285-A1 | METHODS OF TREATING HARD TISSUE WITH BIOCOMPATIBLE MATERIAL | ROCHAL TECHNOLOGIES LLC (US) | 2025-10-16 | — | — | WO | disclosed |
| US-20250319229-A1 | METHODS OF TREATING HARD TISSUE WITH BIOCOMPATIBLE MATERIAL | ROCHAL TECHNOLOGIES LLC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12264275-B2 | Treatment liquid | FUJIFILM CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| CN-118931672-A | Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate | 富士胶片株式会社 | 2024-11-12 | — | — | CN | disclosed |
| CN-118931673-A | Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate | 富士胶片株式会社 | 2024-11-12 | — | — | CN | disclosed |
| US-20010046824-A1 | Textile coating composition | NIGAM ASUTOSH (US) | 2001-11-29 | — | — | US | disclosed |
| US-6291023-B1 | APPLYING TO SURFACE OF TEXTILE SUBSTRATE COATING COMPOSITION CONTAINING AGENT SELECTED FROM MIXTURE OF AZETIDINIUM POLYMER AND GUANIDINE POLYMER, COPOLYMER OF AZETIDINIUM MONOMER AND GUANIDINE MONOMER, AND POLY(AMINOAMIDE)-EPICHLOROHYDRIN RESIN | SRI INTERNATIONAL | 2001-09-18 | — | — | US | disclosed |
| WO-2001062859-A2 | INKS | AVECIA LIMITED (GB) | 2001-08-30 | — | — | WO | disclosed |
| US-6197880-B1 | EFFICIENTLY BINDS COLORANT UPON PRINTING, AND THUS PROVIDES AN ECONOMICAL, EFFICIENT MEANS FOR PROCESSING OF PAPER TO PROVIDE A HIGH QUALITY PRINTED IMAGE THEREON. | SRI INTERNATIONAL | 2001-03-06 | — | — | US | disclosed |
| US-5380303-A | Method for using an antimicrobial agent for ophthalmic formulations | Holly, Frank J. (US) | 1995-01-10 | — | — | US | disclosed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | disclosed |
| WO-1987005779-A1 | PROPHYLAXIS METHOD AND COMPOSITION THEREFOR | SHACKNAI JONAH | 1987-10-08 | — | — | WO | disclosed |
| US-4022834-A | Antibacterially active hexamethylene-bis-biguanides | A/S FARMACEUTISK INDUSTRI (NO) | 1977-05-10 | — | — | US | disclosed |
| US-4022834-A | Antibacterially active hexamethylene-bis-biguanides | A/S FARMACEUTISK INDUSTRI (NO) | 1977-05-10 | — | — | US | disclosed |
| US-4022834-A | Antibacterially active hexamethylene-bis-biguanides | A/S FARMACEUTISK INDUSTRI (NO) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102455-A1 | ANTIMICROBIAL HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF USING THE SAME | COL1A1, COL2A1, COL14A1 | SMN1; SMN2 4231/4885MEN1 4311/4885CYP1A2 3749/4885 |
| US-20260053136-A1 | SANITIZING AND DISINFECTING COMPOSITIONS WITH DWELL TIME INDICATORS AND CLEANING ARTICLES CONTAINING THE SAME | CUTA, SURF4, SDC1 | SMN1; SMN2 677/4885MEN1 1922/4885CYP1A2 2126/4885 |
| US-12588450-B2 | Post-CMP cleaning liquid comprising a substituted benzene anticorrosive agent, chelant, and amine compound | SSRP1, H1-5, AOC1 | SMN1; SMN2 3451/4885MEN1 4594/4885CYP1A2 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.